查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年的生物分析測試服務市場預測：按類型、分子、工作流程、治療、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1372028

到 2030 年的生物分析測試服務市場預測：按類型、分子、工作流程、治療、最終用戶和地區進行的全球分析

Bioanalytical Testing Services Market Forecasts to 2030 - Global Analysis By Type, Molecule, Workflow, Therapeutic, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球生物分析測試服務市場預計在預測期內將以 12.2% 的年複合成長率成長。

生物分析測試是用來測試生物和生物技術產品的分析過程的術語。分析程序在生物技術和藥品生產中至關重要。藥物研發、開發和商業化都涉及生物分析評估的使用。生物分析測試服務部門是更大的生命科學和醫療保健部門的一個子集，該部門使用組織、血液、尿液和其他體液來收集法規遵循、臨床診斷和研究的關鍵資料。生物樣本，例如。它對許多行業至關重要，包括生物技術、製藥、環境監測、食品安全和臨床研究。

印度製藥協會（IPA）的報告顯示，印度製藥業正以7-8%的成長率成長，預計2030年年度將達到80-900億美元。

更採用品質源自於設計 (QbD)

製藥公司擴大利用品質源於設計 (QbD) 的概念，該概念已被 EMA 和美國FDA 等法規機構廣泛接受，以提高產品品質、製造流程的穩健性和工廠生產力。看起來像這樣。隨著ICH Q8（R2）（藥物開發）、ICH Q9（品質風險管理）和ICH Q10（藥品品質系統）的發布，製藥業的QbD方法與時俱進。未來年度，全球製藥和生物製藥企業擴大接受和使用 QbD 方法，預計將為全球市場的擴張做出重大貢獻。

營運成本高

生物分析測試服務市場受到高營運成本的嚴重限制。這些成本是僱用高技能員工、維護最先進的分析設備和實施嚴格的品管程序所必需的。生物分析所需的昂貴設備的購買和維護成本通常很高。此外，由於需要化學、生物學和資料處理等領域的專業人員，導致人事費用高。較小的公司尤其發現很難透過提供生物分析測試服務來擴張和獲利，並且需要持續投資以保持競爭力並遵守行業標準和立法。這可能會成為。

先進和多功能平台的出現

改進創新方法的先進、靈活平台的出現正在影響生物分析測試服務的成長。生物分析領域最近取得了進步，因為該領域的新方法可以解決所有可能的問題。這些因素預計將推動生物分析測試服務產業的整體成長。重要市場引進了乾血斑法等尖端最尖端科技來檢測藥物動力學。乾血斑法具有許多重要的優點，包括需要少量的處理樣本、易於樣本儲存、減少生物危害問題以及無需採集後處理。因此，先進技術的出現預計將簡化定量過程，從而增加預測期內生物分析測試服務的市場成長。

客戶依賴

生物分析測試服務市場面臨客戶依賴的嚴峻挑戰。如果服務公司過度依賴某些關鍵客戶群，它們可能會在財務上變得脆弱。然而，隨著主要客戶遷移到其他提供者或降低其測試要求，可能會出現嚴重的收益短缺。為了降低這些風險，至關重要的是使您的客戶群多樣化並透過卓越的客戶服務和附加價值服務來維持牢固的客戶關係。透過客戶群多元化，公司可以減少單一客戶的潛在損失，並確保在競爭激烈的生物分析測試市場中實現更穩定和永續的成長。

COVID-19 的影響

COVID-19 的傳播減少了工業部門的產出，並對多家全球企業產生了重大影響，導致對有效疫苗、治療方法和其他醫療服務的需求增加。因此，疫情期間生物分析檢測服務市場呈現需求成長。醫療保健提供者依靠即時護理服務和篩檢技術來進行早期病毒診斷。此外，操作員還引入了減少處理時間的尖端方法和技術。基本技術包括自動化樣品製備、高效液相層析和質譜。機器人和條碼系統等先進技術在疫情期間已被證明是有效的。

預計樣品製備部分在預測期內將是最大的

樣品製備部分估計佔最大佔有率。分析過程中一個重要的步驟是樣品製備，這是生物分析測試服務市場的一個新興領域。在測試或分析之前，必須仔細、有條理地製備生物樣品。此外，樣品製備技術包括樣品萃取、精製、濃縮，有時還包括變性。該元素對於提高分析技術的靈敏度、特異性和精確度以及實現少量目標化合物的檢測和定量至關重要。

病毒學測試領域預計在預測期內年複合成長率最高

預計病毒檢測產業在預測期內將出現良好成長。生物樣本中病毒的分析和檢測是該市場病毒學檢測的主要焦點。對於臨床研究、藥物開發和公共衛生至關重要。由於新的病毒性疾病和流行病帶來的持續危險，對病毒檢測服務的需求正在增加。本部分對於感染疾病控制和預防至關重要，因為使用多種技術來診斷和測試病毒感染，包括 PCR、血清學和次世代定序。

佔比最大的地區：

由於該地區可用的設施以及美國大型大型製藥企業對研發的投資不斷增加，北美在預測期內獲得了最大的市場佔有率。此外，製藥公司正在努力開發新藥，目前有超過 1,100 種癌症治療藥物處於不同的臨床開發階段。由於輝瑞等主要市場參與者的存在，生物分析測試服務業務正在北美範圍內擴展。

複合年複合成長率最高的地區：

預計亞太地區在預測期內將實現獲利成長。在亞太地區提供生物分析測試服務的組織投資不斷增加、採用這些服務的公司數量不斷增加、企業和法規改革是推動亞太市場的其他因素。專注於建造生技藥品管道的中國和印度小公司以及提供生物分析測試服務的公司擴大採用最尖端科技，例如一次性技術，正在推動市場發展。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭關係

第5章 全球生物分析測試服務市場：按類型

  • 基於細胞的檢測
    • 基於細菌細胞的測定
    • 基於病毒細胞的檢測
  • 病毒測試
    • 體外病毒檢測
    • 體內病毒檢測
    • 種特異性病毒檢測
  • 最佳化方法開發
  • 血清學、免疫抗原性
  • 生物標記測試
  • 藥物動力學研究
  • 生物利用度測試
  • 生物等效性研究
  • 動態測試
  • 其他類型

第6章 全球生物分析測試服務市場：依分子分類

  • 低分子
  • 高分子
    • 液質聯用研究
    • 免疫學測試
      • 藥物動力學
      • 抗藥物抗體
  • 其他分子

第7章 全球生物分析測試服務市場：依工作流程

  • 樣品製備
    • 液態萃取
    • 蛋白質沉澱
    • 固相萃取
  • 樣品分析
    • 色譜技術
    • 連字技術
    • 配體結合測定
    • 電泳
    • 核磁共振
    • 質譜
  • 其他工作流程

第8章 全球生物分析測試服務市場：按處理方式

  • 血液學
  • 神經病學
  • 代謝紊亂
  • 腫瘤學
  • 免疫學
  • 整形外科
  • 其他治療方法

第9章 全球生物分析測試服務市場：依最終用戶分類

  • 製藥和生物技術公司
  • 合約研究組織
  • 其他最終用戶

第10章 全球生物分析測試服務市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • Syneos Health
  • Intertek Group
  • Medpace
  • PPD, Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America
  • Pace Analytical Services
  • ICON plc
  • PRA Health Sciences
  • Charles River Laboratories International, Inc.
  • WuXi AppTec
  • SGS SA Toxikon, Inc.
  • IQVIA
  • Pharmaceutical Product Development
  • Frontage Labs
  • Covance Inc.
  • Altasciences
  • BioAgilytix Labs
  • Vipragen Biosciences
  • Bioneeds India Private Limited
Product Code: SMRC24084

According to Stratistics MRC, the Global Bioanalytical Testing Services Market is accounted for $5207.3 million in 2023 and is expected to reach $116.38 million by 2030 growing at a CAGR of 12.2% during the forecast period. Bioanalytical testing is the term for the analytical process used to examine biological and biotechnological products. In the production of biotechnology and pharmaceuticals, analytical procedures are essential. Drug discovery, development, and commercialization all involve the use of bio analytical evaluation. The bio analytical testing services sector is a subset of the larger life sciences and healthcare sectors that focuses on the examination and testing of biological samples, such as tissues, blood, urine, and other bodily fluids, in order to gather important data for regulatory compliance, clinical diagnosis, and research. It is crucial to many industries, including biotechnology, medicines, environmental monitoring, food safety, and clinical research.

According to a report from the Indian Pharmaceutical Alliance (IPA), the Indian pharmaceutical industry was growing at a rate of 7-8% and is estimated to register USD 80-90 billion in annual revenue by 2030.

Market Dynamics:

Driver:

Rising adoption of the quality by design approach

Pharmaceutical companies are increasingly using the Quality-by-Design (QbD) concept, which has been widely embraced by regulatory bodies like the EMA and US FDA, to improve the quality of their products, the robustness of their manufacturing processes, and the productivity of their factories. With the release of ICH Q8 (R2) (pharmaceutical development), ICH Q9 (quality risk management), and ICH Q10 (pharmaceutical quality system), the QbD method in the pharmaceutical business has evolved throughout time. In the upcoming years, it is anticipated that the growing acceptance and use of the QbD approach among pharmaceutical and biopharmaceutical operations around the world will significantly contribute to the expansion of the global market.

Restraint:

High operational costs

The market for bio analytical testing services is significantly constrained by high operational costs. These costs are required in order to hire highly skilled employees, maintain cutting-edge analytical equipment, and implement strict quality control procedures. The pricey equipment needed for bio analysis is frequently expensive to buy and keep up. Furthermore, high labour expenses are a result of the demand for specialised talent in sectors like chemistry, biology, and data processing. Smaller companies in particular may find it challenging to scale their businesses and make a profit from offering bio analytical testing services, and they may need to make continual investments to stay competitive and comply with industry standards and laws.

Opportunity:

Emergence of advanced and versatile platforms

The emergence of sophisticated and flexible platforms that improve innovative methods has had an impact on the growth of bio analytical testing services. The discipline of bio analysis has advanced recently since new approaches in the sector are capable of handling any issues that can arise. These elements are anticipated to boost the industry's overall growth for bio analytical testing services. Prominent markets are implementing cutting-edge technologies, like dry blood spot technology, to measure pharmacokinetics because it has more benefits than other traditional methods. The dry blood spot method has a number of important advantages, including the need for a small processing sample, easy sample storage, reduced biohazard concerns, the lack of post-collection processing, and many more. Therefore, the presence of advanced technologies is simplifying the quantification process and thereby expected to increase the bio analytical testing services market growth during the forecast period.

Threat:

Client dependence

The market for bio analytical testing services faces a serious challenge from client dependence. Services companies may be financially vulnerable if they rely excessively on a select group of important customers. However, a significant revenue shortfall could come from a key client shifting to another provider or reducing their testing requirements. It is crucial to reducing this danger to diversify the client base and retain solid client relationships through outstanding customer service and value-added services. By diversifying their clientele, businesses can reduce their exposure to the potential loss of a single customer and assure steadier, sustainable growth in the competitive bio analytical testing market.

COVID-19 Impact

The spread of COVID-19 has reduced the output of the industrial sectors, and as a result of its significant impact on several worldwide operations, there has been a rise in demand for effective vaccines, treatments, and other medical services. As a result, the market for bio analytical testing services saw an increase in demand during the epidemic. Healthcare providers relied on point of care services and screening techniques for early viral diagnosis in people. Additionally, the businesses have introduced cutting-edge methodologies and technology that have reduced processing time. The essential techniques include automated sample preparation, ultra-performance liquid chromatography, mass spectrometry, and others. Such advanced technologies as robotics and barcode systems have proved efficient during the pandemic.

The sample preparation segment is expected to be the largest during the forecast period

The sample preparation segment is estimated to hold the largest share. An essential step in the analysis process is sample preparation, which is an emerging area in the bio analytical testing services market. Before being tested or analysed, biological samples must be carefully and methodically prepared. Moreover, techniques for sample preparation include sample extraction, purification, concentration, and occasionally alteration. This component is essential for improving the sensitivity, specificity, and accuracy of analytical techniques and allowing the detection and quantification of small amounts of target compounds.

The virology testing segment is expected to have the highest CAGR during the forecast period

The virology testing segment is anticipated to have lucrative growth during the forecast period. The analysis and detection of viruses in biological samples is the primary focus of the virology testing component of the market. It is essential to clinical research, pharmaceutical development, and public health. The need for virology testing services has grown due to the persistent hazards posed by new viral illnesses and pandemics. This section is crucial for the management and prevention of infectious diseases because it uses a variety of techniques to diagnose and examine viral infections, including PCR, serology, and next-generation sequencing.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the facilities available across the region and increasing investment for the R&D from US pharmaceutical titans. Additionally, pharmaceuticals are working very hard to create new medicines and they have developed over 1100 oncology treatments that are in various phases of clinical development. The business for bio analytical testing services is expanding across North America because of the presence of major market players like Pfizer.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. A rise in investments made by organisations offering bio analytical testing services in the region, an increase in the number of companies adopting these services, and corporate and regulatory reforms are other factors driving the market in Asia Pacific. Small enterprises in China and India that are focused on building biologics pipelines, as well as an increase in the pace of adoption of cutting-edge technologies, like single-use technologies, by businesses that provide bio analytical testing services, have boosted the market.

Key players in the market

Some of the key players in the Bioanalytical Testing Services Market include: Syneos Health, Intertek Group, Med pace, PPD, Inc., Euro fins Scientific, Laboratory Corporation of America, Pace Analytical Services, ICON plc, PRA Health Sciences , Charles River Laboratories International, Inc., WuXi App Tec, SGS SA Toxikon, Inc., IQVIA, Pharmaceutical Product Development, Frontage Labs, Covance Inc., Alta sciences, BioAgilytix Labs, Vipragen Biosciences and Bio needs India Private Limited.

Key Developments:

In June 2023, ICON plc, one of the world leaders in CRO and healthcare intelligence, announced the release of its new ICON Digital Platform. The platform facilitates seamless integration of ICON site, patient, site, and sponsor services along with harmonized and customizable data delivery.

In June 2023, Syneos Health, one of the leading companies in biopharmaceutical solutions, announced a patient-centric partnership with uMotif, a clinical trial solutions organization. The collaboration is aimed at aiding the acceleration of clinical trials and introducing new therapies to patients via an end-to-end and more effective digital platform. This platform comprises robust Electronic Patient-reported Outcomes (ePRO) and Electronic Clinical Outcome Assessment (eCOA) capabilities

In May 2023, IQVIA a significant provider of advanced analytics, clinical research services, and technology solutions in the world, announced a strategic partnership RED, to battle against AIDS and the injustices that permit pandemics to thrive. This partnership supports laboratory system strengthening.

Types Covered:

  • Cell-Based Assays
  • Virology Testing
  • Method Development Optimization
  • Serology, Immunogenicity
  • Biomarker Testing
  • Pharmacokinetics Testing
  • Bioavailability Testing
  • Bioequivalence Testing
  • Pharmacodynamics Testing
  • Other Types

Molecules Covered:

  • Small Molecule
  • Large Molecule
  • Other Molecules

Workflows Covered:

  • Sample Preparation
  • Sample Analysis
  • Other Workflows

Therapeutics Covered:

  • Hematology
  • Neurology
  • Metabolic Disorders
  • Oncology
  • Immunology
  • Orthopedics
  • Other Therapeutics

End Users Covered:

  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioanalytical Testing Services Market, By Type

  • 5.1 Introduction
  • 5.2 Cell-Based Assays
    • 5.2.1 Bacterial Cell-Based Assays
    • 5.2.2 Viral Cell-Based Assays
  • 5.3 Virology Testing
    • 5.3.1 In Vitro Virology Testing
    • 5.3.2 In Vivo Virology Testing
    • 5.3.3 Species-Specific Viral Assays
  • 5.4 Method Development Optimization
  • 5.5 Serology, Immunogenicity
  • 5.6 Biomarker Testing
  • 5.7 Pharmacokinetics Testing
  • 5.8 Bioavailability Testing
  • 5.9 Bioequivalence Testing
  • 5.10 Pharmacodynamics Testing
  • 5.11 Other Types

6 Global Bioanalytical Testing Services Market, By Molecule

  • 6.1 Introduction
  • 6.2 Small Molecule
  • 6.3 Large Molecule
    • 6.3.1 LC-MS Studies
    • 6.3.2 Immunoassays
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Anti-Drug Antibody
  • 6.4 Other Molecules

7 Global Bioanalytical Testing Services Market, By Workflow

  • 7.1 Introduction
  • 7.2 Sample Preparation
    • 7.2.1 Liquid-Liquid Extraction
    • 7.2.2 Protein Precipitation
    • 7.2.3 Solid Phase Extraction
  • 7.3 Sample Analysis
    • 7.3.1 Chromatographic Technique
    • 7.3.2 Hyphenated Technique
    • 7.3.3 Ligand Binding Assay
    • 7.3.4 Electrophoresis
    • 7.3.5 Nuclear Magnetic Resonance
    • 7.3.6 Mass Spectrometry
  • 7.4 Other Workflows

8 Global Bioanalytical Testing Services Market, By Therapeutic

  • 8.1 Introduction
  • 8.2 Hematology
  • 8.3 Neurology
  • 8.4 Metabolic Disorders
  • 8.5 Oncology
  • 8.6 Immunology
  • 8.7 Orthopedics
  • 8.8 Other Therapeutics

9 Global Bioanalytical Testing Services Market, By End User

  • 9.1 Introduction
  • 9.2 Pharma & Biotechnology Companies
  • 9.3 Contract Research Organizations
  • 9.4 Other End Users

10 Global Bioanalytical Testing Services Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Syneos Health
  • 12.2 Intertek Group
  • 12.3 Medpace
  • 12.4 PPD, Inc.
  • 12.5 Eurofins Scientific
  • 12.6 Laboratory Corporation of America
  • 12.7 Pace Analytical Services
  • 12.8 ICON plc
  • 12.9 PRA Health Sciences
  • 12.10 Charles River Laboratories International, Inc.
  • 12.11 WuXi AppTec
  • 12.12 SGS SA Toxikon, Inc.
  • 12.13 IQVIA
  • 12.14 Pharmaceutical Product Development
  • 12.15 Frontage Labs
  • 12.16 Covance Inc.
  • 12.17 Altasciences
  • 12.18 BioAgilytix Labs
  • 12.19 Vipragen Biosciences
  • 12.20 Bioneeds India Private Limited

List of Tables

  • Table 1 Global Bioanalytical Testing Services Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioanalytical Testing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Bioanalytical Testing Services Market Outlook, By Cell-Based Assays (2021-2030) ($MN)
  • Table 4 Global Bioanalytical Testing Services Market Outlook, By Bacterial Cell-Based Assays (2021-2030) ($MN)
  • Table 5 Global Bioanalytical Testing Services Market Outlook, By Viral Cell-Based Assays (2021-2030) ($MN)
  • Table 6 Global Bioanalytical Testing Services Market Outlook, By Virology Testing (2021-2030) ($MN)
  • Table 7 Global Bioanalytical Testing Services Market Outlook, By In Vitro Virology Testing (2021-2030) ($MN)
  • Table 8 Global Bioanalytical Testing Services Market Outlook, By In Vivo Virology Testing (2021-2030) ($MN)
  • Table 9 Global Bioanalytical Testing Services Market Outlook, By Species-Specific Viral Assays (2021-2030) ($MN)
  • Table 10 Global Bioanalytical Testing Services Market Outlook, By Method Development Optimization (2021-2030) ($MN)
  • Table 11 Global Bioanalytical Testing Services Market Outlook, By Serology, Immunogenicity (2021-2030) ($MN)
  • Table 12 Global Bioanalytical Testing Services Market Outlook, By Biomarker Testing (2021-2030) ($MN)
  • Table 13 Global Bioanalytical Testing Services Market Outlook, By Pharmacokinetics Testing (2021-2030) ($MN)
  • Table 14 Global Bioanalytical Testing Services Market Outlook, By Bioavailability Testing (2021-2030) ($MN)
  • Table 15 Global Bioanalytical Testing Services Market Outlook, By Bioequivalence Testing (2021-2030) ($MN)
  • Table 16 Global Bioanalytical Testing Services Market Outlook, By Pharmacodynamics Testing (2021-2030) ($MN)
  • Table 17 Global Bioanalytical Testing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 18 Global Bioanalytical Testing Services Market Outlook, By Molecule (2021-2030) ($MN)
  • Table 19 Global Bioanalytical Testing Services Market Outlook, By Small Molecule (2021-2030) ($MN)
  • Table 20 Global Bioanalytical Testing Services Market Outlook, By Large Molecule (2021-2030) ($MN)
  • Table 21 Global Bioanalytical Testing Services Market Outlook, By LC-MS Studies (2021-2030) ($MN)
  • Table 22 Global Bioanalytical Testing Services Market Outlook, By Immunoassays (2021-2030) ($MN)
  • Table 23 Global Bioanalytical Testing Services Market Outlook, By Other Molecules (2021-2030) ($MN)
  • Table 24 Global Bioanalytical Testing Services Market Outlook, By Workflow (2021-2030) ($MN)
  • Table 25 Global Bioanalytical Testing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 26 Global Bioanalytical Testing Services Market Outlook, By Liquid-Liquid Extraction (2021-2030) ($MN)
  • Table 27 Global Bioanalytical Testing Services Market Outlook, By Protein Precipitation (2021-2030) ($MN)
  • Table 28 Global Bioanalytical Testing Services Market Outlook, By Solid Phase Extraction (2021-2030) ($MN)
  • Table 29 Global Bioanalytical Testing Services Market Outlook, By Sample Analysis (2021-2030) ($MN)
  • Table 30 Global Bioanalytical Testing Services Market Outlook, By Chromatographic Technique (2021-2030) ($MN)
  • Table 31 Global Bioanalytical Testing Services Market Outlook, By Hyphenated Technique (2021-2030) ($MN)
  • Table 32 Global Bioanalytical Testing Services Market Outlook, By Ligand Binding Assay (2021-2030) ($MN)
  • Table 33 Global Bioanalytical Testing Services Market Outlook, By Electrophoresis (2021-2030) ($MN)
  • Table 34 Global Bioanalytical Testing Services Market Outlook, By Nuclear Magnetic Resonance (2021-2030) ($MN)
  • Table 35 Global Bioanalytical Testing Services Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
  • Table 36 Global Bioanalytical Testing Services Market Outlook, By Other Workflows (2021-2030) ($MN)
  • Table 37 Global Bioanalytical Testing Services Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 38 Global Bioanalytical Testing Services Market Outlook, By Hematology (2021-2030) ($MN)
  • Table 39 Global Bioanalytical Testing Services Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 40 Global Bioanalytical Testing Services Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
  • Table 41 Global Bioanalytical Testing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 42 Global Bioanalytical Testing Services Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 43 Global Bioanalytical Testing Services Market Outlook, By Orthopedics (2021-2030) ($MN)
  • Table 44 Global Bioanalytical Testing Services Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 45 Global Bioanalytical Testing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Global Bioanalytical Testing Services Market Outlook, By Pharma & Biotechnology Companies (2021-2030) ($MN)
  • Table 47 Global Bioanalytical Testing Services Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 48 Global Bioanalytical Testing Services Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.